Neogen Chemicals Fund Raise of ₹600 Cr

Neogen Chemicals Investor Presentation: Key Takeaways

Q2 FY27 consolidated revenue INR 296 Cr (+42%), EBITDA INR 45 Cr (+51%), PAT INR 8 Cr (+144%). Battery Chemicals revenue INR 37 Cr; Organolithium capacity expansion approved.

Neogen Chemicals Results Update

Neogen Chemicals issued its Q2 FY27 press release on unaudited results, showing higher year-on-year revenue and profit. Battery chemicals ramp-up and the QIP proceeds featured prominently.

Neogen Chemicals Debt & Borrowing: ₹500 Cr

Neogen Chemicals approved in-principle a Rs 500 Crore corporate guarantee for Neogen Morita's borrowings, subject to shareholder approval. The company reports no adverse impact.

Value

₹500.0 Cr

Neogen Chemicals Capacity Expansion: ₹45 Cr Investment

Neogen Chemicals' board approved a capacity addition of 600 MT/PA with a Rs 45.00 Crore investment. Funding will come from internal accruals and debt.

Value

₹45.00 Cr

Execution

By end of next financial year

manufacturing capacity

600.0 MTPA

Neogen Chemicals Other Announcement

Neogen reports no deviation in QIP fund utilisation for the quarter ended September 30, 2026. This is a periodic utilisation report, not a new transaction.

Neogen Chemicals Q2 FY27 Results: Net Profit ₹8.2 Cr, Up 141.2% YoY

Neogen Chemicals Ltd reported revenue from operations of ₹296 Cr (+41.8% YoY) and net profit of ₹8.2 Cr (+141.2% YoY) for Q2 FY27.

Key figure

Net profit ₹8.2 Cr · +141.2% YoY

Rite Zone Chemcon India Fund Raise of ₹6.58 Cr

Rite Zone Chemcon India announced a preferential issue of 27,69,730 equity shares to 11 investors at Rs.24 each, raising about Rs.6.58 Crore. The approval awaits a shareholder vote on 23 November 2026.

Value

₹6.58 Cr

Sudarshan Pharma Industries Fund Raise of ₹72 Cr

Sudarshan Pharma's board approved up to Rs. 72 Crore of preferential convertible warrants for promoters Hemal and Sachin Mehta. Shareholder approval will be sought at an EGM.

Value

₹72.00 Cr

Flywings Simulator Training Centre Fund Raise of ₹68.2 Cr

Flywings Simulator's board approved Rs. 68.20 Crore fully convertible warrants on a preferential basis. Promoter Rupal Mandavia is allotted Rs. 25 Crore, subject to shareholder approval.

Value

₹68.20 Cr

Kanel Industries Fund Raise of ₹16.99 Cr

Kanel Industries' board approved a rights issue of 42.52 lakh equity shares at Rs.39.95 each. The issue aggregates about Rs.16.99 Crore, with record date 13 November 2026.

Value

₹16.99 Cr

Execution

Rights issue opens 23 November 2026 and closes 30 November 2026

Sudarshan Pharma Industries Fund Raise

Board approved issuing up to 72 Crore warrants to promoters on a preferential basis. Pricing per Reg 164 is pending, with no fixed rupee value stated.

GAIL (India) Fund Raise

GAIL Board approved in principle the IPO of subsidiary GAIL Gas Limited on Indian exchanges. GAIL will dilute its GGL equity up to 25%.